Milestone Pharmaceuticals Inc.
MIST | NASDAQ
$0.92
$0 (+0.46%)
At close: Sep 21, 2026, 4:00 PM ET
$0.92
$0 (-0.24%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.69 | -3.52 | -1.20 | -2.93 | -6.42 | -3.94 |
PEG Ratio | -0.23 | 0.07 | -0.41 | -0.09 | 0.16 | 0.08 |
PS Ratio | 109.60 | n/a | 71.74 | 33.62 | 18.27 | n/a |
PB Ratio | 4.06 | 11.17 | 4.28 | 2.53 | 2.43 | 1.37 |
P/FCF Ratio | -3.43 | -5.08 | -1.54 | -3.19 | -8.25 | -3.88 |
P/OCF Ratio | -3.46 | -5.09 | -1.55 | -3.20 | -8.25 | -3.88 |
OCF/S Ratio | -3.17K | n/a | -4.64K | -1.05K | -221.49 | n/a |
Debt / Equity Ratio | 1.40 | 4.17 | 3.09 | 0.04 | 0.01 | 0.01 |
Quick Ratio | 7.96 | 9.10 | 10.11 | 11.70 | 17.55 | 24.14 |
Current Ratio | 8.01 | 9.10 | 10.11 | 11.70 | 17.55 | 24.14 |
Asset Turnover | 0.01 | n/a | 0.01 | 0.07 | 0.13 | n/a |
Interest Coverage | -16.28 | 11.76 | -23.92 | n/a | n/a | -69.85 |
Return on Equity | -150.97% | -315.81% | -355.88% | -88% | -38.06% | -34.91% |
Return on Assets | -55.53% | -54.99% | -79.34% | -78.39% | -35.76% | -33.32% |
Return on Invested Capital | -62% | -61.97% | -89.13% | -86.64% | -38.02% | -35.19% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 92.63% | n/a | 100% | 100% | 100% | n/a |
Net Profit Margin | -4.08K% | n/a | -5.97K% | -1.17K% | -285.69% | n/a |
Pretax Profit Margin | -4.1K% | n/a | -5.97K% | -1.17K% | -285.69% | n/a |
Operating Profit Margin | -4.04K% | n/a | -6.11K% | -1.19K% | -287.15% | n/a |
FCF Margin | -3.19K% | n/a | -4.65K% | -1.05K% | -221.49% | n/a |
EBITDA Margin | -3.85K% | n/a | -5.7K% | -1.17K% | -285.07% | n/a |
Add to Watchlist
Select watchlists to add or remove MIST